(Q42646021)

4 November 2017

title

Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). (English)

1 reference

4 November 2017

0 references

0 references

0 references

1 reference

Barrero FJ

1

1 reference

4 November 2017

Ampuero I

2

1 reference

4 November 2017

Morales B

3

1 reference

4 November 2017

Vives F

4

1 reference

4 November 2017

de Dios Luna Del Castillo J

5

1 reference

4 November 2017

Hoenicka J

6

1 reference

4 November 2017

García Yébenes J

7

1 reference

4 November 2017

language of work or name

1 reference

1 January 2005

1 reference

The Pharmacogenomics Journal

4 November 2017

published in

1 reference

4 November 2017

volume

5

1 reference

4 November 2017

issue

2

1 reference

4 November 2017

page(s)

135-141

1 reference

Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson's disease.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Depression and Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

The occurrence of depression in Parkinson's disease. A community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Prevalence, etiology, and treatment of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Effect of age at onset on frequency of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Depression, intellectual impairment, and Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

The correlation of depression with functional activity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

The cannabinoid receptor: biochemical, anatomical and behavioral characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Motor actions of cannabinoids in the basal ganglia output nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Cannabis-associated psychosis with hypomanic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Localization of cannabinoid receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Relationships between motivation and depression in chronic marijuana users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Involvement of CB1 cannabinoid receptors in emotional behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Parkin and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Genetics of Parkinsonism: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Variability and validity of polymorphism association studies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Association study between cannabinoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Cannabinoid receptor gene (CNR1): association with i.v. drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Emerging targets for the treatment of depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

Epidemiology of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

7 January 2021

Childhood adversity, gender and depression over the life-course

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

7 January 2021

Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

7 January 2021

No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

7 January 2021

Depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

7 January 2021

Depression in classic versus akinetic-rigid Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

7 January 2021

Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500301

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500301

1 reference

4 November 2017

1 reference